The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of
@IDSAinfo
We are very excited to announce the launch of a new series: “Voices of ID”!
Dedicated to personal stories written in the author’s unique voice, “Voices of ID” explores the ways in which our work in infectious diseases intersects with our daily lives.
🧵 Continued ⬇️ (1/5)
Hi everyone! 👋 We're the official account for Clinical Infectious Diseases. An official journal of
@IDSAinfo
, CID is one of the world's leading journals on ID. Follow us to stay up to date and comment on high-quality articles on clinical ID, public health, microbiology & more.
We are pleased to announce the members of our incoming editorial board, under the leadership of our new Editor-in-Chief
@PaulSaxMD
!
See the full editorial roster here ➡️
Utility of Differential Time to Positivity in Diagnosing Central Line–Associated Bloodstream Infections: A Systematic Review and Meta-Analysis
🆓 Freely Available
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
🆓 Freely Available
🔗
Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate
🔗
Is short-course antibiotic therapy suitable for Pseudomonas aeruginosa bloodstream infections in onco-hematology patients with febrile neutropenia? Results of a multi-institutional analysis
✅ Just Accepted
🔓 Open Access
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
✅ Just Accepted
🆓 Freely Available
🔗
Is short-course antibiotic therapy suitable for Pseudomonas aeruginosa bloodstream infections in onco-hematology patients with febrile neutropenia? Results of a multi-institutional analysis
🔓 Open Access
Is short-course antibiotic therapy suitable for Pseudomonas aeruginosa bloodstream infections in onco-hematology patients with febrile neutropenia? Results of a multi-institutional analysis
🔓 Open Access
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults
🆓 Freely Available
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)*
✅ Just Accepted
🆓 Freely Available
🔗
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
✅ Just Accepted
🔓 Open Access
🔗
Nirmatrelvir resistance – de novo E166V/L50V mutations in an immunocompromised patient treated with prolonged nirmatrelvir/ritonavir monotherapy leading to clinical and virological treatment failure – a case report
✅ Just Accepted
🔗
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice
🔓 Open Access
Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study
✅ Just Accepted
🔗
Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary HIV Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial
🔓 Open Access
Rifampin Based Therapy for Patients with Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-Analysis
✅ Just Accepted
via
@MDTande
@SaidElZein2
@JulianMaamari
🆕 State of the Art Review 🆕
Here,
@SandyNelsonMD
and colleagues share their current approaches to the diagnosis and management of periprosthetic joint infection, focusing on frequent clinical challenges and collaborative interdisciplinary care.
🔗
Mutation rate of AmpC-β-lactamase-producing Enterobacterales and treatment in clinical practice: A word of caution
✅ Just Accepted
✍️
@AlMaillard
et al.
Unintended Consequences: Risk of Opportunistic Infections Associated With Long-term Glucocorticoid Therapies in Adults
✅ Just Accepted
🆓 Freely Available
🔗
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)*
✅ Just Accepted
🆓 Freely Available
🔗
Unintended Consequences: Risk of Opportunistic Infections Associated With Long-term Glucocorticoid Therapies in Adults
✅ Just Accepted
🆓 Freely Available
🔗
Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice
🔓 Open Access
As 2023 comes to a close, the editors-in-chief of CID,
@JIDJournal
, and
@OFIDJournal
wish to share a curated selection of 15 outstanding papers from across all three IDSA journals.
⬇️ Browse the collection via the link below ⬇️
🔗
Utility of Differential Time to Positivity in Diagnosing Central Line–Associated Bloodstream Infections: A Systematic Review and Meta-Analysis
🆓 Freely Available
Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials
✅ Just Accepted
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection: 152-week results from ATLAS-2M, a randomized, open-label, Phase 3b, noninferiority study
✅ Just Accepted
🔓 Open Access
🔗
Are contact precautions “essential” for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?
✅ Just Accepted
🆓 Freely Available
🔗
via
@dan_diekema
@dr_dmorgan
Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study
✅ Just Accepted
@KottonNelson
Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study
✅ Just Accepted
🔓 Open Access
🔗
Mutation rate of AmpC-β-lactamase-producing Enterobacterales and treatment in clinical practice: A word of caution
✅ Just Accepted
✍️
@AlMaillard
et al.
Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis
🔓 Open Access
Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study
✅ Just Accepted
🔓 Open Access
🔗
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
✅ Just Accepted
🆓 Freely Available
via
@boulware_dr
et al.
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response
✅ Just Accepted
🔓 Open Access
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
✅ Just Accepted
🔓 Open Access
🔗
Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial
✅ Just Accepted
🆓 Freely Available
The Xpert® MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort
✅ Just Accepted
🆓 Freely Available
Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia
✅ Just Accepted
🔗
Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
🔓 Open Access
Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines
🔗
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
✅ Just Accepted
🔓 Open Access
🔗
An open-label, randomized trial comparing fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients receiving concomitant antibiotics for concurrent infections
✅ Just Accepted
🔗